389 related articles for article (PubMed ID: 33098092)
1. Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).
Xu Y; Zhu Y; Hu S; Xu Y; Stroup D; Pan X; Bawa FC; Chen S; Gopoju R; Yin L; Zhang Y
Hepatology; 2021 Jun; 73(6):2251-2265. PubMed ID: 33098092
[TBL] [Abstract][Full Text] [Related]
2. High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice.
Yu D; Chen G; Pan M; Zhang J; He W; Liu Y; Nian X; Sheng L; Xu B
J Cell Physiol; 2018 Jun; 233(6):4770-4782. PubMed ID: 29150932
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease.
Pan X; Zhang Y
Chin Med J (Engl); 2022 May; 135(10):1172-1181. PubMed ID: 35191422
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
[TBL] [Abstract][Full Text] [Related]
5. Krüppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4α-mediated metabolic pathways.
Pan X; Hu S; Xu Y; Gopoju R; Zhu Y; Cassim Bawa FN; Wang H; Wang J; Batayneh Z; Clark A; Zeng Y; Lin L; Wang X; Yin L; Zhang Y
Metabolism; 2024 Jun; 155():155909. PubMed ID: 38582490
[TBL] [Abstract][Full Text] [Related]
6. Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4alpha.
Inoue Y; Yu AM; Yim SH; Ma X; Krausz KW; Inoue J; Xiang CC; Brownstein MJ; Eggertsen G; Björkhem I; Gonzalez FJ
J Lipid Res; 2006 Jan; 47(1):215-27. PubMed ID: 16264197
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease.
Xu Y; Zhu Y; Hu S; Pan X; Bawa FC; Wang HH; Wang DQ; Yin L; Zhang Y
Mol Metab; 2021 Sep; 51():101244. PubMed ID: 33930596
[TBL] [Abstract][Full Text] [Related]
8. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
9. Hepatocytic Activating Transcription Factor 3 Protects Against Steatohepatitis via Hepatocyte Nuclear Factor 4α.
Xu Y; Hu S; Jadhav K; Zhu Y; Pan X; Bawa FC; Yin L; Zhang Y
Diabetes; 2021 Nov; 70(11):2506-2517. PubMed ID: 34475098
[TBL] [Abstract][Full Text] [Related]
10. Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice.
Li Y; Zalzala M; Jadhav K; Xu Y; Kasumov T; Yin L; Zhang Y
Hepatology; 2016 Jun; 63(6):1860-74. PubMed ID: 26806650
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte-Specific Loss of PPARγ Protects Mice From NASH and Increases the Therapeutic Effects of Rosiglitazone in the Liver.
Lee SM; Pusec CM; Norris GH; De Jesus A; Diaz-Ruiz A; Muratalla J; Sarmento-Cabral A; Guzman G; Layden BT; Cordoba-Chacon J
Cell Mol Gastroenterol Hepatol; 2021; 11(5):1291-1311. PubMed ID: 33444819
[TBL] [Abstract][Full Text] [Related]
12. 6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade.
Ahn J; Lee H; Jung CH; Ha SY; Seo HD; Kim YI; Ha T
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1201-1213. PubMed ID: 34139323
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism.
Xu Y; Li Y; Jadhav K; Pan X; Zhu Y; Hu S; Chen S; Chen L; Tang Y; Wang HH; Yang L; Wang DQ; Yin L; Zhang Y
Nat Metab; 2021 Jan; 3(1):59-74. PubMed ID: 33462514
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte-specific loss of LAP2α protects against diet-induced hepatic steatosis, steatohepatitis, and fibrosis in male mice.
Upadhyay KK; Choi EK; Foisner R; Omary MB; Brady GF
Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G184-G195. PubMed ID: 37366543
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk of hepatocyte nuclear factor 4a and glucocorticoid receptor in the regulation of lipid metabolism in mice fed a high-fat-high-sugar diet.
Lu H; Lei X; Winkler R; John S; Kumar D; Li W; Alnouti Y
Lipids Health Dis; 2022 May; 21(1):46. PubMed ID: 35614477
[TBL] [Abstract][Full Text] [Related]
16. Hepatic hepatocyte nuclear factor 4α is essential for maintaining triglyceride and cholesterol homeostasis.
Yin L; Ma H; Ge X; Edwards PA; Zhang Y
Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):328-36. PubMed ID: 21071704
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice.
Lee SM; Muratalla J; Karimi S; Diaz-Ruiz A; Frutos MD; Guzman G; Ramos-Molina B; Cordoba-Chacon J
Cell Mol Life Sci; 2023 Jan; 80(2):39. PubMed ID: 36629912
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4alpha in mediating bile acid repression.
Zhang M; Chiang JY
J Biol Chem; 2001 Nov; 276(45):41690-9. PubMed ID: 11535594
[TBL] [Abstract][Full Text] [Related]
19. A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism.
Xu Y; Zalzala M; Xu J; Li Y; Yin L; Zhang Y
Nat Commun; 2015 Jun; 6():7466. PubMed ID: 26100857
[TBL] [Abstract][Full Text] [Related]
20. Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis.
Goto T; Itoh M; Suganami T; Kanai S; Shirakawa I; Sakai T; Asakawa M; Yoneyama T; Kai T; Ogawa Y
Sci Rep; 2018 May; 8(1):8157. PubMed ID: 29802399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]